Lebenthal Holdings’s Elevance Health ELV Stock Holding History

Lebenthal Holdings’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$359K	Sell	2,732 -704	-20%	-$96.3K	0.04%	287
2016 Q1	$477K	Buy	3,436 +59	+2%	+$7.88K	0.08%	255
2015 Q4	$471K	Sell	3,377 -21	-0.6%	-$2.89K	0.11%	221
2015 Q3	$475K	Buy	3,398 +68	+2%	+$10.2K	0.11%	224
2015 Q2	$546K	Sell	3,330 -241	-7%	-$38.5K	0.11%	211
2015 Q1	$551K	Sell	3,571 -7,779	-69%	-$1.11M	0.13%	208
2014 Q4	$1.43M	Buy	+11,350	New	+$1.4M	0.63%	42

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Lebenthal Holdings's ELV Position: Q2 2016 in Review

Lebenthal Holdings reduced its Elevance Health (ELV) stake by 20% in Q2 2016, selling an estimated $96.3K and leaving 2,732 shares worth $359K. The position accounts for 0.04% of the portfolio, ranked #287.

Lebenthal Holdings first reported a position in ELV in Q4 2014 and has held it in 7 quarters since. The position peaked at $1.43M in Q4 2014. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Lebenthal Holdings held 2,732 shares of Elevance Health worth $359K as of Q2 2016.
Lebenthal Holdings sold 704 Elevance Health shares in Q2 2016, an estimated $96.3K.
Elevance Health made up 0.04% of Lebenthal Holdings's portfolio in Q2 2016, its #287 holding.
Lebenthal Holdings first reported a position in Elevance Health in Q4 2014 and has held it in 7 quarters since.
Lebenthal Holdings's Elevance Health position peaked at $1.43M in Q4 2014.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.